These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


108 related items for PubMed ID: 714379

  • 1. Slow-release artificial tears and the treatment of keratitis sicca.
    Katz JI, Kaufman HE, Breslin C, Katz IM.
    Ophthalmology; 1978 Aug; 85(8):787-93. PubMed ID: 714379
    [Abstract] [Full Text] [Related]

  • 2. A clinical study of slow-releasing artificial tears.
    Lamberts DW, Langston DP, Chu W.
    Ophthalmology; 1978 Aug; 85(8):794-800. PubMed ID: 714380
    [Abstract] [Full Text] [Related]

  • 3. Effect of osmolarity of artificial tear drops on relief of dry eye symptoms: BJ6 and beyond.
    Wright P, Cooper M, Gilvarry AM.
    Br J Ophthalmol; 1987 Feb; 71(2):161-4. PubMed ID: 3548809
    [Abstract] [Full Text] [Related]

  • 4. The use of slow-release artificial tears in the long-term management of keratitis sicca.
    Werblin TP, Rheinstrom SD, Kaufman HE.
    Ophthalmology; 1981 Jan; 88(1):78-81. PubMed ID: 7243230
    [Abstract] [Full Text] [Related]

  • 5. [Value of inserts in the treatment of dry eye syndromes (preliminary results)].
    Huguet P, Colin J, Renard G.
    Bull Soc Ophtalmol Fr; 1981 Dec; 81(12):1173-7. PubMed ID: 7343154
    [No Abstract] [Full Text] [Related]

  • 6. The efficacy of cellulosic ophthalmic inserts for treatment of dry eye.
    LaMotte J, Grossman E, Hersch J.
    J Am Optom Assoc; 1985 Apr; 56(4):298-302. PubMed ID: 3989212
    [Abstract] [Full Text] [Related]

  • 7. Slow-release artificial tear inserts in the treatment of dry eyes in patients with rheumatoid arthritis.
    Hill JC.
    Br J Ophthalmol; 1989 Feb; 73(2):151-4. PubMed ID: 2649149
    [Abstract] [Full Text] [Related]

  • 8. [Hydroxypropylmethyl-containing eyedrops in the treatment of sicca syndrome].
    Török M.
    Klin Monbl Augenheilkd; 1985 Jul; 187(1):60-2. PubMed ID: 4068574
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Instillation of 0.1% hyaluronic acid in severe keratitis sicca].
    Tabatabay C.
    J Fr Ophtalmol; 1985 Jul; 8(6-7):513. PubMed ID: 4078229
    [No Abstract] [Full Text] [Related]

  • 11. A comparative clinical study of tear substitutes in normal subjects and in patients with keratoconjunctivitis sicca.
    Marner K, Prause JU.
    Acta Ophthalmol (Copenh); 1984 Feb; 62(1):91-5. PubMed ID: 6202090
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tear diluents in the treatment of keratoconjunctivitis sicca.
    Gilbard JP, Kenyon KR.
    Ophthalmology; 1985 May; 92(5):646-50. PubMed ID: 4011138
    [Abstract] [Full Text] [Related]

  • 15. [Current treatments of xerophthalmia in Sjögren's syndrome].
    Baudouin C, Pisella PJ, Brignole F.
    Rev Med Interne; 2004 May; 25(5):376-82. PubMed ID: 15110955
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Biomicroscopy of the tear film: aqueous and lipid tear substitutes in the normal and abnormal eye.
    Carrington S, Bedford PG, Guillon JP, Carlile JL, Woodward EG.
    Vet Rec; 1988 Sep 24; 123(13):329-35. PubMed ID: 3195015
    [Abstract] [Full Text] [Related]

  • 18. A comparison of the effect of carbomer-, cellulose- and mineral oil-based artificial tear formulations.
    Wang IJ, Lin IC, Hou YC, Hu FR.
    Eur J Ophthalmol; 2007 Sep 24; 17(2):151-9. PubMed ID: 17415686
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Artificial tears developed by the author in a case of keratoconjunctivitis sicca].
    Andrzejewska W, Stolarska H, Klera C, Kirylowicz K.
    Klin Oczna; 1972 Sep 24; 42(3):889-91. PubMed ID: 5030425
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.